Page 230 - Abstract Book KONIKA 18
P. 230

Hemato-Oncology

                                         P-HO-008 (Prime e-Poster)
              The Evaluation of Inflammation Factors (C-Reactive Protein Level) Based on
                       Bleeding Manifestation and Substitution Factors Exposure
                                       in Hemophilia A Patients

                              Ati Rahmipurwandari, Dasril Daud, Nadirah Rasyid Ridha
                       Department of Child Health, Faculty of Medicine Universitas Hasanuddin, Makassar
                                               Abstract
            Background Hemophilia patients have a risk of recurring and prolonged bleeding that will affect the
            inflammatory response to form C-Reactive Protein (CRP). The evaluation of CRP level based on bleeding
            manifestation and substitution factors exposure in patients with hemophilia A has never been studies in
            Indonesia. Objective To evaluate factors associated with inflammation (CRP level) based on bleeding
            manifestation and substitution factors exposure in hemophilia A patients. Methods This cross sectional
            study was based on primary data of children with hemophilia A 3 months - 18 years of age from Hospital
            of Dr. Wahidin Sudirohusodo of Makassar, South Sulawesi. Measurement of inhibitor status, CRP level,
            bleeding manifestation, and substitution factors exposure were conducted simultaneously.  Results Of the
            34 subjects, there are 26 hemophilia A patients with inhibitor and 8 without inhibitor. Bivariate analysis
            showed significant correlation between CRP level with bleeding manifestation in hemophilia A group with
            inhibitor (P=0.016; OR 0.004; 95%CI 0.004 to 0.484] with cut-off point is 3.67 mg/dL), but not in hemophilia
            A without inhibitor (P=0.470). No significant correlation between CRP level with age when first exposed
            (≤ 1 and > 1 years old) and intensity of the substitution factor exposure within a month (< 2 times and ≥ 2
            times) in hemophilia A with inhibitor as well as without inhibitor. Conclusion There is a relationship between
            inflammatory factors (CRP level) with bleeding manifestation in hemophilia A patients with inhibitors, the
            cut-off point is 3.67 mg/dL.
                         Keywords: hemophilia; inflammation; inhibitors; bleeding; C-Reactive Protein



                                               P-HO-009
                    Vitamin K Deficiency Bleeding with Eye Proptosis Manifestation:
                                            A Case Report

                                        Avian Andika, Teny Tjitra Sari
              Department of Child Health, Faculty of Medicine Universitas Indonesia,Cipto Mangunkusumo General Hospital,
                                             Jakarta, Indonesia
                                               Abstract
            Background Vitamin K deficiency bleeding (VKDB, also known as acquired prothrombin complex deficiency,
            APCD) was a rare coagulation disorder caused by vitamin K deficiency in infants with multiple bleeding
            manifestations such as skin hemorrhage, gastrointestinal bleeding, umbilical bleeding, cephalhematoma,
            and intracranial hemorrhage. There were high rate of mortalities and morbidities caused by VKDB.
            Objective To demonstrate eye proptosis as an unusual bleeding manifestation of VKDB. Case A 5-month-
            old boy came to the emergency unit with protruding left eye that grew larger since 6 hours prior to hospital
            admission. The patient has history of predominantly breastfed, not given vitamin K prophylaxis at birth,
            and has cholestasis since the neonatal period. Bulging fontanel was found from physical examination. From
            ophthalmologic examination and orbital CT scan, the patient has retrobulbar hemorrhage causing left eye
            proptosis. Few hours after admission, the patient develops seizure caused by intracranial hemorrhage. The
            laboratory examination showed prolonged PT and aPTT, normocytic normochromic anemia, and cholestasis.
            The patient was diagnosed with retrobulbar and intracranial hemorrhage caused by vitamin K deficiency
            bleeding, compressive optic neuropathy and cholestasis. Vitamin K injection were done to normalized
            PT and aPTT values and stop the bleeding, and canthotomy and cantholysis procedure performed by
            ophthalmologic department to reduce orbital pressure. Conclusion One of the unusual manifestation of
            VKDB is retrobulbar hemorrhage that presents with eye proptosis. Vitamin K injection remains to be the
            mainstay therapy. Pediatricians should understand how to diagnose vitamin K deficiency bleeding early to
            prevent mortalities and morbidities.
                                  Keywords: vitamin K deficiency bleeding; proptosis



            182                           KONIKA XVIII Abstract Book
   225   226   227   228   229   230   231   232   233   234   235